SUCCESSFUL TENOFOVIR TREATMENT FOR FULMINANT HEPATITIS B INFECTION IN AN INFANT

被引:15
作者
Diamanti, Antonella [1 ,4 ]
Sartorelli, Maria Rita [1 ,4 ]
Alterio, Arianna [1 ,4 ]
Comparcola, Donatella [1 ,4 ]
Corsetti, Tiziana [2 ]
Iacono, Anna [2 ]
Pizzichemi, Giuseppe [3 ]
Nobili, Valerio [1 ,4 ]
de Goyet, Jean de Ville [1 ,4 ]
Torre, Guiliano [1 ,4 ]
机构
[1] Bambino Gesu Children Hosp, Transplantat Ctr, I-00165 Rome, Italy
[2] Bambino Gesu Children Hosp, Hosp Pharm Unit, I-00165 Rome, Italy
[3] Bambino Gesu Children Hosp, Microbiol Unit, I-00165 Rome, Italy
[4] Bambino Gesu Children Hosp, Liver Unit, I-00165 Rome, Italy
关键词
fulminant liver failure; hepatitis B; infant; tenofovir; LAMIVUDINE TREATMENT; CHILDREN; THERAPY; FAILURE; VACCINATION; CARRIER; SAFETY; AREAS; BORN;
D O I
10.1097/INF.0b013e31821e23b3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fulminant hepatic failure is defined by the presence of severe impairment of liver function, with or without encephalopathy, in patients with no underlying chronic liver disease. We report the case of a 4-month-old infant who developed fulminant hepatitis B infection and recovered concomitant with tenofovir therapy without liver transplantation.
引用
收藏
页码:912 / 914
页数:3
相关论文
共 50 条
  • [21] Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir
    Ezequiel Ridruejo
    World Journal of Gastroenterology, 2014, (23) : 7169 - 7180
  • [22] Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection
    Wai-Kay Seto
    Man-Fung Yuen
    James Fung
    Ching-Lung Lai
    Hepatology International, 2013, 7 : 327 - 334
  • [23] Tenofovir treatment of the severe acute hepatitis B
    Casals-Seoane, Fernando
    Arberas-Diez, Beatriz
    Garcia-Buey, Luisa
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (01) : 57 - 59
  • [24] Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience
    Tarsetti, Fabio
    Tarantino, Giuseppe
    Mosca, Piergiorgio
    Scarpellini, Emidio
    Fava, Giammarco
    CLINICAL MANAGEMENT ISSUES, 2015, 9 (04) : 95 - 100
  • [25] Comparing the frequency of osteoporosis and osteopenia in chronic hepatitis B patients with and without Tenofovir treatment
    Hajiani, Eskandar
    Parsi, Abazar
    Seyedian, Seyed Saeed
    Rajaei, Elham
    Jolodarian, Parisa
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2020, 8 (02): : 428 - 431
  • [26] Lamivudine treatment in infantile fulminant hepatitis B
    Chen, Ching-Yi
    Ni, Yen-Hsuan
    Chen, Huey-Ling
    Lu, Frank Leigh
    Chang, Mei-Hwei
    PEDIATRICS INTERNATIONAL, 2010, 52 (04) : 672 - 674
  • [27] Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
    Rodriguez, Manuel
    Manuel Pascasio, Juan
    Fraga, Enrique
    Fuentes, Javier
    Prieto, Martin
    Sanchez-Antolin, Gloria
    Luis Calleja, Jose
    Molina, Esther
    Luisa Garcia-Buey, Maria
    Angeles Blanco, Maria
    Salmeron, Javier
    Lucia Bonet, Maria
    Antonio Pons, Jose
    Manuel Gonzalez, Jose
    Angel Casado, Miguel
    Jorquera, Francisco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (41) : 7459 - 7469
  • [28] Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection
    Marcellin, Patrick
    Wong, David K.
    Sievert, William
    Buggisch, Peter
    Petersen, Joerg
    Flisiak, Robert
    Manns, Michael
    Kaita, Kelly
    Krastev, Zahari
    Lee, Samuel S.
    Cathcart, Andrea L.
    Crans, Gerald
    Op den Brouw, Marjoleine
    Jump, Belinda
    Gaggar, Anuj
    Flaherty, John
    Buti, Maria
    LIVER INTERNATIONAL, 2019, 39 (10) : 1868 - 1875
  • [29] Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
    Ataei, Behrooz
    Khodadoostan, Mahsa
    Pouria, Babk
    Adibi, Peyman
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2016, 5 (03) : 166 - 170
  • [30] Evaluation of Tenofovir Disoproxil Fumarate Treatment in Patients with Chronic Hepatitis B
    Konya, Petek
    Demirturk, Nese
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (01): : 47 - 54